Caloric Restriction for Canine Healthspan & Longevity

Background: Caloric restriction (CR) without malnutrition is the most consistently replicated intervention for extending lifespan and healthspan across biological species. While extensively studied in laboratory models, the canine evidence base is uniquely robust, anchored by a 14-year controlled longitudinal study and corroborated by large-scale observational data from tens of thousands of companion dogs living in naturalistic settings.

Objective: To synthesize the current peer-reviewed evidence on caloric restriction — including dietary quantity, meal timing, and pharmacological CR mimetics — as it pertains to canine longevity, healthspan, and age-related disease prevention, and to translate these findings into actionable protocols for longevity-focused pet owners.

Methods: A narrative review of the primary literature was conducted, incorporating the Purina Life Span Study (Kealy et al., 2002; Lawler et al., 2008), the Dog Aging Project meal frequency analysis (Bray et al., 2022), the Salt et al. (2019) body condition and lifespan retrospective, the Wang et al. (2007) metabonomic investigation of CR in dogs, and current clinical trial data on rapamycin (TRIAD study) and longevity-targeted pharmacology (Loyal LOY-002). Epidemiological data on canine obesity prevalence and owner perception were also incorporated.

Results: A 25% sustained caloric restriction extended median lifespan in Labrador Retrievers by 1.8 years (15%) and delayed the onset of chronic disease by 2 years compared to ad libitum-fed controls. Across 12 breeds and 50,787 client-owned dogs, overweight body condition in middle age was associated with a median lifespan reduction of 0.4 to 2.5 years depending on breed, with hazard ratios for death ranging from 1.35 to 2.86. In a cross-sectional analysis of 24,238 companion dogs, once-daily feeding was associated with significantly lower odds of gastrointestinal (OR 0.65), kidney/urinary (OR 0.71), orthopedic (OR 0.78), dental (OR 0.84), and liver/pancreatic disorders (OR 0.41), as well as superior cognitive function scores equivalent to a four-year cognitive age advantage. Mechanistically, CR modulates the IGF-1/insulin signaling axis, inhibits mTOR to upregulate autophagy, activates AMPK, and remodels the gut microbiome — the same conserved longevity pathways targeted by emerging pharmacological interventions including rapamycin and LOY-002. Despite this evidence, approximately 65% of US dogs are currently overweight or obese, and 83% of their owners do not recognize it.

Conclusions: Caloric restriction — operationalized as maintaining a lean body condition score of 4–5/9, precise calorie management, and consideration of time-restricted feeding — represents the highest-impact, lowest-cost longevity intervention available to companion dog owners today. The convergence of dietary CR principles with emerging CR-mimetic pharmacology (rapamycin, LOY-002) and epigenetic age-tracking tools is rapidly transforming canine longevity from a passive hope into an active, measurable protocol. The primary barrier to implementation is not scientific uncertainty but owner education and perception.

Introduction and Key Findings

Caloric restriction (CR) without malnutrition is the most robust, consistently replicated, and mechanistically understood intervention for extending both lifespan and healthspan across virtually every species studied — from nematodes and yeast to rodents, primates, and companion dogs. Unlike many longevity interventions that are extrapolated from laboratory models, the canine evidence for CR is unusually direct and clinically powerful, anchored by a 14-year controlled longitudinal study and corroborated by large-scale observational data from tens of thousands of companion dogs. For the proactive pet owner, the implications are profound: the single most impactful longevity lever available today is not a supplement, drug, or therapy — it is the discipline of keeping a dog lean throughout its life.

The core findings from the current body of evidence can be summarized as follows. A sustained 25% reduction in caloric intake, initiated in early life and maintained without causing malnutrition, extended the median lifespan of Labrador Retrievers by 1.8 years — a 15% increase — in the landmark Purina Life Span Study [1]. Beyond raw lifespan, the lean-fed dogs experienced a 2-year delay in the onset of chronic age-related diseases, meaning they not only lived longer but spent a significantly greater proportion of their lives in good health [1]. Complementing this, a large-scale retrospective study of over 50,000 client-owned dogs across 12 breeds found that overweight dogs had a median lifespan up to 2.5 years shorter than their ideal-weight counterparts, with the effect observed universally across all breeds studied [2]. The Dog Aging Project's analysis of 24,238 companion dogs further revealed that the timing of feeding is independently associated with health outcomes, with once-daily fed dogs showing significantly lower odds of gastrointestinal, dental, orthopedic, kidney, and liver disorders, as well as better cognitive function scores [3]. At the molecular level, CR exerts its effects by downregulating the IGF-1/insulin signaling axis, inhibiting the mTOR complex, activating AMPK, and upregulating autophagy — the same conserved longevity pathways targeted by the most promising pharmacological interventions in geroscience today [4].

Data and Statistics

The Purina Life Span Study: The Gold Standard in Canine CR Research

The Purina Life Span Study remains the most rigorous and comprehensive investigation of caloric restriction in dogs ever conducted. Initiated in 1987 and completed in 2001, the study followed 48 Labrador Retrievers from seven litters over their entire lifetimes. Dogs were paired at 8 weeks of age by sex and weight, with one dog in each pair assigned to a control group fed ad libitum and the other to a lean-fed group receiving 25% fewer calories. The diet composition was identical; only the quantity differed. The study was designed to be free from confounders such as breed variability, environmental differences, and dietary composition, making it the closest thing to a controlled human lifespan trial that exists in biomedical research.

Source: Kealy et al., 2002, JAVMA [1]; Lawler et al., 2008, British Journal of Nutrition [13]

The study's most clinically significant finding was not merely the lifespan extension but the compression of morbidity. Lean-fed dogs required treatment for chronic conditions — including osteoarthritis, which was the most common age-related disease in this cohort — an average of two years later than their control counterparts. This is the canine equivalent of the human longevity ideal: not just more years, but more healthy years.

Body Condition Score and Lifespan: The Salt et al. (2019) Study

The largest study to examine the relationship between body condition and lifespan in client-owned dogs was published in the Journal of Veterinary Internal Medicine in 2019. The retrospective analysis examined over 50,787 middle-aged (6.5–8.5 years), neutered client-owned dogs attending approximately 900 veterinary hospitals across North America, spanning 12 popular breeds. For each breed and sex, dogs in "overweight" body condition were compared to those in "normal" body condition using Cox proportional hazards models.

The results were unambiguous: for every breed studied, overweight dogs had a significantly higher instantaneous risk of death and a shorter median lifespan than their ideal-weight counterparts. The hazard ratios for death ranged from 1.35 for German Shepherd Dogs to 2.86 for Yorkshire Terriers, meaning overweight Yorkies were nearly three times more likely to die at any given age than their lean peers [2].

Source: Salt et al., 2019, JVIM [2] (approximate values from published data)

The Dog Aging Project: Meal Frequency and Health Outcomes

The 2022 Dog Aging Project analysis by Bray et al. is the largest study of feeding frequency in companion dogs ever conducted, leveraging a cross-sectional dataset of 24,238 dogs for health outcomes and 10,474 dogs for cognitive function assessment. The study found that dogs fed once daily — representing 8% of the total sample — had statistically significantly lower odds of five of the nine health categories examined, after controlling for age, sex, breed, body size, and omega-3 supplementation [3].

Source: Bray et al., 2022, GeroScience [3]

The cognitive finding is particularly striking: the 0.62-point difference in the Canine Cognitive Dysfunction Rating Scale score between once-daily and more-frequently fed dogs is equivalent to the cognitive difference between a 7-year-old and an 11-year-old dog — a four-year cognitive age advantage simply from meal timing [3].

The Canine Obesity Epidemic: The Baseline Problem

The context for all of this data is a pet population that is, by and large, already failing the most basic longevity intervention. The Association for Pet Obesity Prevention's 2025 data estimates that 65% of dogs in the United States are overweight or obese [14]. Compounding this, a 2024 survey found that only 17% of dog owners acknowledged that their pet was overweight, meaning the vast majority of owners of overweight dogs believe their pet is at a normal weight [12]. This perceptual gap is the single greatest barrier to implementing CR in practice.

Mechanisms of Action

Understanding why caloric restriction works is essential for understanding how to replicate its benefits through dietary, pharmacological, and lifestyle interventions. CR does not work through a single mechanism; rather, it simultaneously modulates multiple interconnected longevity pathways that collectively slow the hallmarks of aging.

IGF-1 / Insulin Signaling Axis. The most well-characterized mechanism of CR is the reduction in circulating insulin and insulin-like growth factor 1 (IGF-1). In a fed state, high insulin and IGF-1 levels activate the PI3K/Akt signaling cascade, which promotes cellular growth and proliferation but suppresses stress resistance and longevity pathways. CR reduces IGF-1 levels, shifting cells from a growth-oriented to a maintenance-oriented state. This is directly relevant to dogs: large breeds, which have chronically elevated IGF-1 due to selective breeding for size, age faster and die younger than small breeds — a phenomenon that is the inverse of the typical mammalian size-lifespan relationship [15]. LOY-001, Loyal's drug candidate for large-breed dogs, works specifically by targeting the IGF-1 pathway to pharmacologically replicate this CR-like effect [9].

mTOR Inhibition and Autophagy. The mechanistic target of rapamycin (mTOR) is a master regulator of cellular metabolism that integrates nutrient availability with cellular growth decisions. When calories are abundant, mTOR is active, promoting protein synthesis and cell growth while suppressing autophagy — the cellular "self-cleaning" process that removes damaged proteins and organelles. CR inhibits mTOR, thereby upregulating autophagy and allowing cells to clear the molecular debris that accumulates with age. Impaired autophagy is a hallmark of aging and is implicated in neurodegenerative diseases, cancer, and metabolic dysfunction. The drug rapamycin replicates this specific effect of CR by directly inhibiting mTOR, which is the mechanistic basis for its use as a CR mimetic [5].

AMPK Activation. AMP-activated protein kinase (AMPK) is the cell's primary energy sensor, activated when the AMP:ATP ratio rises during caloric deficit. AMPK activation promotes mitochondrial biogenesis, fatty acid oxidation, and glucose uptake, while simultaneously inhibiting mTOR. It also activates sirtuins, a family of NAD+-dependent deacetylases that regulate gene expression in response to metabolic stress. The net effect is a shift toward cellular efficiency, stress resistance, and longevity.

Gut Microbiome Remodeling. A fascinating and underappreciated mechanism of CR's longevity effects is its impact on the gut microbiome. Research by Professor Jeremy Nicholson and colleagues at Imperial College London, using the Purina Life Span Study dogs, found that caloric restriction significantly altered the composition and metabolic activity of the gut microbiota. Specifically, CR-fed dogs showed changes in microbial populations that produce short-chain fatty acids and modify bile acid metabolism, which in turn influence systemic inflammation, immune function, and metabolic health [8]. The metabolomics analysis by Wang et al. (2007), also using the Purina Life Span Study cohort, identified distinct urinary and plasma metabolic signatures in CR dogs, including altered taurine, choline, and trimethylamine metabolism, suggesting that the gut microbiome is a key mediator of CR's systemic effects [16].

Expert Opinions and Quotes

The veterinary and geroscience communities are increasingly aligned on the importance of lean body condition as a foundational longevity intervention.

"The study showed that a 25% restriction in food intake, without causing malnutrition, can extend the median lifespan of dogs by nearly two years. This is a powerful demonstration of the impact of diet on health and longevity." — Purina Institute [1]

"The Association of Pet Obesity Prevention now has the prevalence of dogs who are overweight to obese at approximately 60 percent of the pet population, nearly mimicking human rates of obesity. Having been involved in nutrition for over 25 years now, I recognize that this is one of the hardest conditions to treat in veterinary medicine." — Dr. Joseph Wakshlag, DVM, PhD, DACVN, Cornell University College of Veterinary Medicine [6]

"Changes caused to bugs in the gut by restricting calorie intake may partly explain why dietary restriction can extend lifespan, according to new research on dogs. The research suggests that gut microbes could underpin the benefits of a low-calorie diet on longevity." — Professor Jeremy Nicholson, Imperial College London [8]

"Given the intense interest in, and popularization of, 'longevity diets' such as intermittent fasting and time-restricted feeding, these types of studies in dogs are both timely and important. We believe these studies will ultimately offer insights into factors that promote health and longevity for both dogs and humans." — Bray et al., Dog Aging Project, GeroScience 2022 [3]

Emerging Trends and Predictions

The field of canine longevity is experiencing a rapid acceleration, with several converging trends poised to transform how CR principles are applied in veterinary practice.

Caloric Restriction Mimetics and the TRIAD Study. The most significant near-term development is the ongoing Test of Rapamycin in Aging Dogs (TRIAD), a prospective, double-masked, randomized, placebo-controlled multicenter clinical trial evaluating the effects of low-dose weekly rapamycin on healthspan and lifespan in companion dogs [5]. Rapamycin mimics the mTOR-inhibitory effects of CR without requiring dietary restriction, making it potentially the most powerful CR mimetic available. Preliminary data from earlier pilot studies showed improvements in cardiac function in middle-aged dogs on rapamycin, and the TRIAD study is powered to detect meaningful differences in lifespan and age-related disease incidence. Results from this trial will be among the most important data points in canine longevity science in the coming years.

Loyal's LOY-002 and the First FDA-Approved Longevity Drug. Loyal, a San Francisco-based longevity biotech company, is pursuing FDA approval for LOY-002, a drug designed to extend healthy lifespan in senior dogs by targeting metabolic aging pathways. As of February 2026, Loyal has completed two of the three major FDA requirements for Expanded Conditional Approval — safety and efficacy acceptance — and has fully enrolled the STAY pivotal efficacy trial, with over 1,300 dogs across 70+ veterinary clinics nationwide [9]. If approved, LOY-002 would be the first FDA-approved drug for lifespan extension in any species, representing a watershed moment for both veterinary medicine and human longevity science.

Epigenetic Clocks as CR Biomarkers. The development of DNA methylation-based epigenetic clocks for dogs allows for the objective measurement of biological age, independent of chronological age. These tools are being actively used to assess whether CR and CR-mimetic interventions actually slow the epigenetic aging rate. Loyal has in-licensed a mouse-canine-human homogeneous epigenetic clock from UCSD, which will allow direct comparison of aging rates across species and provide a quantitative endpoint for longevity trials [10]. For pet owners, these clocks may eventually become commercially available as a tool to track whether their dog's lifestyle interventions are working at the biological level.

Time-Restricted Feeding as a Mainstream Protocol. The Dog Aging Project's findings on once-daily feeding are expected to prompt a reassessment of the current standard veterinary recommendation of twice-daily feeding for adult dogs. As longitudinal data from the DAP accumulates, the causal relationship between meal timing and health outcomes will be clarified, potentially leading to updated clinical guidelines that incorporate time-restricted feeding as a standard longevity recommendation.

Controversial Viewpoints and Debates

Despite the strength of the evidence, several important controversies and limitations must be acknowledged by any practitioner or owner considering CR protocols.

The GDV Debate. The most clinically significant controversy surrounding once-daily feeding — the most practical form of CR for companion dogs — is the potential risk of gastric dilatation-volvulus (GDV) in large and giant breed dogs. A 2004 study by Raghavan et al. found that the risk of GDV was highest for large and giant breed dogs fed a larger volume of food once daily [11]. This finding has been the basis for the longstanding veterinary recommendation to feed large breeds twice daily. However, the 2022 Dog Aging Project study, which is orders of magnitude larger, found that once-daily feeding was associated with lower odds of gastrointestinal disorders overall. The discrepancy likely reflects the difference between GDV specifically (a rare but catastrophic event) and gastrointestinal health generally. The current consensus is that once-daily feeding may be appropriate for most dogs, but owners of large, deep-chested breeds (Great Danes, Dobermans, Standard Poodles, Weimaraners, Irish Setters) should exercise caution, consider splitting meals, and discuss the risk-benefit profile with their veterinarian.

Generalizability Beyond Labrador Retrievers. The Purina Life Span Study, while methodologically rigorous, was conducted exclusively on Labrador Retrievers housed in a controlled kennel environment. Critics rightly question whether the 1.8-year lifespan extension is generalizable to the full diversity of companion dog breeds, sizes, and lifestyles. Labrador Retrievers are a large breed with a well-documented predisposition to obesity and a moderate lifespan; the proportional benefit of CR may be different in small breeds that already live 15+ years, or in giant breeds where metabolic and aging dynamics are fundamentally different. The Salt et al. (2019) study provides some reassurance that the principle of lean body condition benefiting lifespan holds across breeds, but the magnitude of the benefit varies considerably.

The Owner Perception Gap. Perhaps the most intractable challenge in applying CR research to companion dogs is the "fat pet gap" — the well-documented disconnect between veterinary assessment and owner perception of their dog's body condition. A 2024 survey found that only 17% of dog owners acknowledged their pet was overweight, with 84% of dog owners assessing their overweight pets as normal or thin [12]. This is not merely a knowledge gap; it reflects deeply ingrained emotional associations between food, love, and caregiving. Veterinarians report that discussing a dog's weight is among the most challenging conversations in clinical practice, often met with denial or defensiveness. Effective implementation of CR principles requires not just owner education but a fundamental reframing of how food and portion control are perceived as acts of love rather than deprivation.

CR in Puppies and Seniors. Caloric restriction is explicitly contraindicated in growing puppies, where adequate caloric and nutrient intake is essential for normal skeletal and muscular development. Restricting calories in large-breed puppies, in particular, can paradoxically increase the risk of developmental orthopedic diseases. At the other end of the age spectrum, very senior dogs may require increased caloric density to maintain muscle mass and body weight, as sarcopenia and reduced digestive efficiency become dominant concerns. CR protocols must therefore be age-appropriate and regularly reassessed throughout the dog's life.

Practical Implications for Pet Owners

The research on caloric restriction translates into a clear, actionable framework for longevity-focused pet owners. The following protocol represents the current best-practice synthesis of the available evidence.

Master the Body Condition Score. The foundational skill for any owner committed to canine longevity is the ability to accurately assess their dog's Body Condition Score (BCS) on a 9-point scale. A score of 4–5/9 is the target: ribs should be easily palpable with minimal fat covering, a visible waist should be apparent when viewed from above, and an abdominal tuck should be present when viewed from the side. Owners should perform this assessment monthly and not rely solely on weight, as muscle mass and fat distribution matter as much as the number on the scale. Veterinary confirmation of BCS at every wellness visit is essential, particularly given the documented tendency for owners to underestimate their dog's body fat.

Implement Precise Calorie Management. Vague recommendations to "feed less" are insufficient. Effective CR requires knowing the dog's current caloric intake, establishing a target based on ideal body weight (not current weight), and tracking intake including treats, toppers, and table scraps. A practical formula for weight loss, recommended by veterinary nutritionists, is to calculate the Resting Energy Requirement (RER) at the dog's ideal body weight: RER (kcal/day) = 70 × (ideal weight in kg)^0.75, then multiply by a factor of 1.0–1.2 for weight loss. All treats should be factored into the daily caloric budget, and low-calorie options such as raw vegetables (green beans, baby carrots, bell pepper) should be substituted for high-calorie commercial treats wherever possible [6].

Consider Time-Restricted Feeding. For adult dogs without a high risk for GDV, transitioning to once-daily feeding or a compressed feeding window (e.g., all daily calories delivered within a 6–8 hour window) is a practical and evidence-supported strategy. The Dog Aging Project data suggests that meal timing has independent health effects beyond simple calorie restriction, likely mediated by circadian rhythm entrainment, gut microbiome modulation, and metabolic cycling between fed and fasted states. For large and deep-chested breeds, the GDV risk should be discussed with a veterinarian before implementing once-daily feeding; splitting the daily ration into two smaller meals within a compressed window may offer a reasonable compromise.

Prioritize Nutrient Density During Restriction. A reduction in caloric volume must not compromise nutritional completeness. When feeding less food, every calorie must count more. This argues for high-quality, nutrient-dense diets over calorie-diluted "lite" formulations, which often achieve lower caloric density by adding water or indigestible fiber at the expense of bioavailable protein and micronutrients. Senior and weight management diets formulated by board-certified veterinary nutritionists are preferable to generic over-the-counter options. Maintaining adequate protein intake during CR is particularly important to preserve lean muscle mass and prevent sarcopenia, which becomes a competing concern as dogs age.

Track, Adjust, and Reassess. Caloric needs are not static. They change with age, activity level, reproductive status, season, and health status. A dog that was appropriately lean at age 5 may require a 20–30% reduction in calories by age 10 simply due to the decline in metabolic rate that accompanies aging. Regular BCS assessments, quarterly weigh-ins, and annual veterinary nutritional consultations are the minimum standard for a proactive longevity protocol. As emerging tools such as epigenetic age clocks become commercially available, they will offer a more direct measure of whether the CR protocol is achieving its intended biological effect.

References

[1] Kealy, R. D., Lawler, D. F., Ballam, J. M., Mantz, S. L., Biery, D. N., Greeley, E. H., ... & Stowe, H. D. (2002). Effects of diet restriction on life span and age-related changes in dogs. Journal of the American Veterinary Medical Association, 220(9), 1315–1320. https://avmajournals.avma.org/view/journals/javma/220/9/javma.2002.220.1315.xml

[2] Salt, C., Morris, P. J., Wilson, D., Lund, E. M., & German, A. J. (2019). Association between life span and body condition in neutered client-owned dogs. Journal of Veterinary Internal Medicine, 33(1), 89–99. https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15367

[3] Bray, E. E., Zheng, Z., Tolbert, M. K., McCoy, B. M., Kaeberlein, M., & Kerr, K. F. (2022). Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project. GeroScience, 44(3), 1779–1790. https://pmc.ncbi.nlm.nih.gov/articles/PMC9213604/

[4] Green, C. L., Lamming, D. W., & Fontana, L. (2022). Molecular mechanisms of dietary restriction promoting health and longevity. Nature Reviews Molecular Cell Biology, 23(1), 56–73. https://pmc.ncbi.nlm.nih.gov/articles/PMC8692439/

[5] Coleman, A. E., & Urfer, S. R. (2025). Rapamycin as a potential intervention to promote longevity and extend healthspan in companion dogs. Journal of Veterinary Science, 26(Suppl 1), S181–S198. https://pmc.ncbi.nlm.nih.gov/articles/PMC12520851/

[6] Cornell University College of Veterinary Medicine. (n.d.). The biggest health problem in canine medicine: Obesity. Riney Canine Health Center. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/biggest-health-problem-canine-medicine-obesity

[7] BSM Partners. (2025, June 5). Want Your Pet to Live Longer? Start with This Simple Health Check. https://www.bsmpartners.net/insights/want-your-pet-to-live-longer-start-with-this-simple-health-check/

[8] Imperial College London. (2007, April 12). Dog study sheds new light on why dietary restriction can extend lifespan. https://www.imperial.ac.uk/news/9914/dog-study-sheds-light-dietary-restriction/

[9] Loyal. (2026, February 11). Loyal's Series C: $100M to advance the first longevity drug. https://loyal.com/posts/100m-for-first-longevity-drug

[10] Thompson, M. J., vonholdt, B., Horvath, S., & Pellegrini, M. (2017). An epigenetic aging clock for dogs and wolves. Aging, 9(3), 1055–1068. https://www.aging-us.com/article/101211/text

[11] Raghavan, M., Glickman, N. W., McCabe, G., Lantz, G., & Glickman, L. T. (2004). Diet-related risk factors for gastric dilatation-volvulus in dogs of high-risk breeds. Journal of the American Animal Hospital Association, 40(3), 192–203. https://pubmed.ncbi.nlm.nih.gov/15131099/

[12] Association for Pet Obesity Prevention. (2024, May 6). Survey Reveals Pet Owners Don't Recognize Excess Weight. https://www.petobesityprevention.org/articlesandnews/survey-reveals-pet-owners-dont-recognize-excess-weight-struggle-with-pet-weight-loss-and-give-lots-of-dog-treats

[13] Lawler, D. F., Evans, R. H., Larson, B. T., Spitznagel, E. L., Ellersieck, M. R., & Kealy, R. D. (2008). Diet restriction and ageing in the dog: major observations over two decades. British Journal of Nutrition, 99(4), 793–805. https://pubmed.ncbi.nlm.nih.gov/18062831/

[14] Association for Pet Obesity Prevention. (2025). U.S. Pet Obesity Report. https://www.petobesityprevention.org/dogbcs

[15] Ko, W. H., & Promislow, D. E. L. (2025). Diverse breeds, diverse lifespans: understanding longevity in dogs. Journal of Veterinary Science, 26(Suppl 1). https://pmc.ncbi.nlm.nih.gov/articles/PMC12520860/

[16] Wang, Y., Lawler, D., Larson, B., Ramadan, Z., Kochhar, S., Holmes, E., & Nicholson, J. K. (2007). Metabonomic investigations of aging and caloric restriction in a life-long dog study. Journal of Proteome Research, 6(5), 1846–1854. https://pubs.acs.org/doi/10.1021/pr060685n